Abstract
In this essay crucial problems of the origin of cancer and the development of malignancy are discussed. The problem of precancer and three ways leading to malignancy are considered: induction of tumor precursors, accumulation of genetic traits common for tumor growth, and the role of inflammation in tumor induction. The nature of viral oncogenes and modes of their action are described in the context of their origin as a component of the viral genome. Oncogenes of RNA-containing viruses and DNA-containing tumorigenic viruses are described together with cellular protooncogenes, which are progenitors of RNA-containing viral oncogenes. Hematological malignancies are described as an intermediate form between simple tumors induced by a single oncogene and more complicated epithelial tumors. The roles of tumor suppressor genes and the interaction of several oncogenes in the formation of carcinomas and also the role of progression in tumor evolution are discussed.
Similar content being viewed by others
Abbreviations
- AFP:
-
alpha-fetoprotein
- CLL:
-
chronic lymphoblast leukemia
- CML:
-
chronic myeloid leukemia
- ECM:
-
extracellular matrix
- EMT:
-
epithelial-mesenchymal transition
- FISH:
-
fluorescent in situ hybridization
- GSA:
-
group-specific antigen
- LOH:
-
loss of heterozygosity
- MGCV:
-
mammary gland cancer virus of low oncogenicity
- MMP:
-
membrane met-alloproteinases
- PCR:
-
polymerase chain reaction
- RSV:
-
Rous sarcoma virus
- VEGF:
-
vascular endothelium growth factor
- VIGF:
-
VEGF inhibitor
References
Weinberg, R. (2006) The Biology of Cancer, Garland Science, New York.
Shabad, L. M. (1967) Precancer in Experimental and Morphological Aspects [in Russian], Meditsina, Moscow.
IARC Monographs on the Evaluations of Carcinogenic Risks for Humans (1995) Vol. 53, Hepatitis Viruses, IARC, Lion, France.
The EUROGAST Study Group (1993) Lancet, 341, 1359–1362.
Abelev, G. I. (1979) in Tumor Growth as a Problem of Developmental Biology (Gelstein, V. I., ed.) [in Russian], Nauka, Moscow, pp. 148–173.
Tenen, D. G. (2003) Nat. Rev. Cancer, 3, 89–101.
Huntly, B. J. P., and Gilliland, G. (2005) Nat. Rev., 5, 311–321.
Moore, K. A., and Lemischka, I. R. (2006) Science, 311, 1880–1885.
Weinberg, R. (2006) The Biology of Cancer, Chap. 16, The Rational Treatment of Cancer, Garland Science, New York, pp. 725–795.
Dean, M., Fojo, T., and Bates, S. (2005) Nat. Rev. Cancer, 5, 275–284.
Tenen, D. G., Hromas, R., Licht, J. D., and Zany, D.-E. (1997) Blood, 90, 489–519.
Abelev, G. I. (2007) in Clinical Oncohematology (Volkova, M. A., ed.) [in Russian], 2nd Edn., Meditsina, Moscow, pp. 167–176.
Olovnikov, A. M. (1971) Dokl. Akad. Nauk SSSR, 201, 1496–1499.
Daser, A., and Rabbitts, T. (2004) Genes Dev., 18, 965–974.
Weinberg, R. (2006) The Biology of Cancer, Chap. 10, Eternal Life: Cell Immortalization, Garland Science, New York, pp. 725–795.
Duesberg, P., Fabarius, A., and Hehlmann, R. (2004) Life, 56, 65–81.
Laconi, S., Pillai, S., Porcu, P. P., Shafritz, D. A., Pani, P., and Laconi, E. (2001) Am. J. Pathol., 158, 771–777.
Laconi, S., Pani, P., Pillai, S., Pasciu, D., Sarma, D. S. R., and Laconi, E. (2001) Proc. Natl. Acad. Sci. USA, 98, 7807–7811.
Sell, S., Hunt, J. M., Knoll, B. J., and Dunsford, H. A. (1987) Adv. Cancer Res., 48, 37–111.
Greenberg, A. K., Yee, H., and Rom, W. N. (2002) Respir. Res., 3, 20–30.
Cozzio, A., Passegue, E., Ayton, P. M., Karsunky, H., Cleary, M. L., and Weissman, I. L. (2003) Genes Dev., 17, 3029–3035.
Weinberg, R. (2006) The Biology of Cancer, Chap. 8, Rb and Control of Cell Cycle Clock, Garland Science, New York, pp. 255–306.
Knudson, A. G. (1971) Proc. Natl. Acad. Sci. USA, 68, 820–823.
Calderon-Margalit, R., and Paltiel, O. (2004) Int. J. Cancer, 112, 357–364.
Vogelstein, B., Fearon, E. R., Hamilton, S. R., Kern, S. E., Preisinger, A. C., Leppert, M., Nakamura, Y., White, R., Smits, A. M., and Bos, J. L. N. (1988) Engl. J. Med., 319, 525–532.
Daley, G. Q., van Etten, R. A., and Baltimore, D. (1990) Science, 247, 824–830.
Weinberg, R. (2006) The Biology of Cancer, Chap. 9, P53 and Apoptosis: Master Guard and Executor, Garland Science, New York, pp. 307–356.
Kern, S. E. (1993) J. Nat. Cancer Inst., 85, 1020–1021.
Bhowmick, N. A., and Moses, H. L. (2005) Curr. Opin. Genet. Dev., 15, 97–101.
Hussain, S. P., and Harris, C. C. (2007) Int. J. Cancer, 121, 2373–2380.
Mueller, M. M., and Fusenig, N. E. (2004) Nat. Rev. Cancer, 4, 839–849.
Federico, A., Morgillo, F., Tuccillo, C., Ciardiello, F., and Loguercio, C. (2007) Int. J. Cancer, 121, 2381–2386.
Nedospasov, S. A., and Kuprash, D. V. (2004) in Carcinogenesis (Zaridze, D. G., ed.) [in Russian], Meditsina, Moscow, pp. 158–168.
Li, Q., Withoff, S., and Verma, I. M. (2005) Trends Immunol., 26, 318–325.
Zaridze, D. G. (2004) in Carcinogenesis (Zaridze, D. G., ed.) [in Russian], Meditsina, Moscow, pp. 29–85.
Karamysheva, A. F. (2004) in Carcinogenesis (Zaridze, D. G., ed.) [in Russian], Meditsina, Moscow, pp. 429–447.
Weinberg, R. (2006) The Biology of Cancer, Chap. 13, Dialogue Replaces Monologue: Heterotypic Interactions and the Biology of Angiogenesis, Garland Science, New York, pp. 527–587.
Stetler-Stevenson, W., and Yu, A. E. (2001) Sem. Cancer Biol., 11, 143–152.
Zilber, L. A., Irlin, I. S., and Kiselev, F. L. (1975) Evolution of the Virus-Genetic Theory of Tumor Arising, Chap. 8, Endogenous Viruses and “Normal” Therapy [in Russian], Nauka, Moscow, pp. 242–310.
Weinberg, R. (2006) The Biology of Cancer, Chap. 3, Tumor Viruses, Garland Science, New York, pp. 57–90.
Altstein, A. D. (1973) Zh. Vsesoyuzn. Khim. Obshch. im. Mendeleeva, 18, 631–636.
Weiss, R., Teich, N., Varmus, H., and Coffin, J. (eds.) (1982) RNA Tumor Viruses, Cold Spring Harbor, NY, pp. 1–396.
Bentvelzen, P. (1968) in Genetic Controls of the Vertical Transmission of the Muhlbock Mammary Tumor Virus in the GR Mouse Strain, Hollandia Publisher Co., Amsterdam, p. 1.
Tatosyan, A. G. (2004) in Carcinogenesis (Zaridze, D. G., ed.) [in Russian], Meditsina, Moscow, pp. 103–124.
Weinberg, R. (2006) The Biology of Cancer, Chap. 4, Cellular Oncogenesis, Garland Science, New York, pp. 91–118.
Weinberg, R. (2006) The Biology of Cancer, Chap. 7, Tumor Suppressor Genes, Garland Science, New York, pp. 209–254.
Altstein, A. D. (2004) in Carcinogenesis (Zaridze, D. G., ed.) [in Russian], Meditsina, Moscow, pp. 251–274.
Fleishman, E. V. (2007) in Clinical Oncohematology (Volkova, M. A, ed.) [in Russian], 2nd Edn., Meditsina, Moscow, pp. 370–408.
Hanahan, D., and Weinberg, R. A. (2000) Cell, 100, 57–70.
Hallek, M., Bergsagel, P. L., and Anderson, K. C. (1998) Blood, 91, 3–21.
Kuppers, R. (2005) Nat. Rev. Cancer, 5, 251–262.
Kopnin, B. P. (2004) in Encyclopedia of Clinical Oncology (Davydov, M. I., ed.) [in Russian], RLS-Press, pp. 34–53.
Schwartz, M. A. (1997) J. Cell Biol., 139, 575–578.
Ruoslahti, E. (1999) Adv. Cancer Res., 76, 1–20.
Schmeichel, K. L., and Bissell, M. J. (2003) J. Cell Sci., 116, 2377–2388.
Bissell, M. J., Radisky, D. C., Rizki, A., Weaver, V. M., and Petersen, O. W. (2002) Differentiation, 70, 537–546.
Radisky, D., and Bissel, M. J. (2004) Science, 303, 775–777.
Abelev, G. I., and Lazarevich, N. L. (2006) Adv. Cancer Res., 95, 61–113.
Thiery, J. P. (2002) Nat. Rev. Cancer, 2, 442–454.
Javaherian, A., Vaccariello, M., Fusenig, N. F., and Garlick, J. A. (1998) Cancer Res., 58, 2200–2208.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © G. I. Abelev, T. L. Eraiser, 2008, published in Biokhimiya, 2008, Vol. 73, No. 5, pp. 605–618.
Rights and permissions
About this article
Cite this article
Abelev, G.I., Eraiser, T.L. On the path to understanding the nature of cancer. Biochemistry Moscow 73, 487–497 (2008). https://doi.org/10.1134/S0006297908050015
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0006297908050015